|
4YFK
Escherichia coli RNA polymerase in complex with squaramide compound 8.
Deposited 2015-02-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain E
1–91(91 aa)
|
Not recorded
|
MG MAGNESIUM ION × 2
ZN ZINC ION × 2
4C6 3,5-dimethyl-N-{2-[4-(4-methylbenzyl)piperidin-1-yl]-3,4-dioxocyclobut-1-en-1-yl}-1,2-oxazole-4-sulfonamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;300 K;0.1M HEPES-HCL, 0.2M CaACETATE, 15% PEG400
|
Resolution 3.57 Å
R-free 0.252
|
|
4YFK
Escherichia coli RNA polymerase in complex with squaramide compound 8.
Deposited 2015-02-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain K
1–91(91 aa)
|
Not recorded
|
MG MAGNESIUM ION × 2
ZN ZINC ION × 2
4C6 3,5-dimethyl-N-{2-[4-(4-methylbenzyl)piperidin-1-yl]-3,4-dioxocyclobut-1-en-1-yl}-1,2-oxazole-4-sulfonamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;300 K;0.1M HEPES-HCL, 0.2M CaACETATE, 15% PEG400
|
Resolution 3.57 Å
R-free 0.252
|
|
4YFN
Escherichia coli RNA polymerase in complex with squaramide compound 14 (N-[3,4-dioxo-2-(4-{[4-(trifluoromethyl)benzyl]amino}piperidin-1-yl)cyclobut-1-en-1-yl]-3,5-dimethyl-1,2-oxazole-4-sulfonamide)
Deposited 2015-02-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain E
1–91(91 aa)
|
Not recorded
|
MG MAGNESIUM ION × 1
ZN ZINC ION × 2
4C2 N-[3,4-dioxo-2-(4-{[4-(trifluoromethyl)benzyl]amino}piperidin-1-yl)cyclobut-1-en-1-yl]-3,5-dimethyl-1,2-oxazole-4-sulfonamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;300 K;0.1M HEPES-HCL (PH7), 0.2M CaACETATE, 15% PEG400
|
Resolution 3.82 Å
R-free 0.270
|
|
4YFN
Escherichia coli RNA polymerase in complex with squaramide compound 14 (N-[3,4-dioxo-2-(4-{[4-(trifluoromethyl)benzyl]amino}piperidin-1-yl)cyclobut-1-en-1-yl]-3,5-dimethyl-1,2-oxazole-4-sulfonamide)
Deposited 2015-02-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain K
1–91(91 aa)
|
Not recorded
|
MG MAGNESIUM ION × 1
ZN ZINC ION × 2
4C2 N-[3,4-dioxo-2-(4-{[4-(trifluoromethyl)benzyl]amino}piperidin-1-yl)cyclobut-1-en-1-yl]-3,5-dimethyl-1,2-oxazole-4-sulfonamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;300 K;0.1M HEPES-HCL (PH7), 0.2M CaACETATE, 15% PEG400
|
Resolution 3.82 Å
R-free 0.270
|
|
4YFX
Escherichia coli RNA polymerase in complex with Myxopyronin B
Deposited 2015-02-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain E
1–91(91 aa)
|
Not recorded
|
MG MAGNESIUM ION × 1
ZN ZINC ION × 2
4C4 Myxopyronin B × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7;300 K;0.1M HEPES-HCL , 0.2M CaACETATE, 15% PEG400
|
Resolution 3.84 Å
R-free 0.300
|
|
4YFX
Escherichia coli RNA polymerase in complex with Myxopyronin B
Deposited 2015-02-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain K
1–91(91 aa)
|
Not recorded
|
MG MAGNESIUM ION × 1
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7;300 K;0.1M HEPES-HCL , 0.2M CaACETATE, 15% PEG400
|
Resolution 3.84 Å
R-free 0.300
|
|
4YLN
E. coli Transcription Initiation Complex - 17-bp spacer and 4-nt RNA
Deposited 2015-03-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 6
PDB declaration: nonameric
|
Chain E
2–91(90 aa)
|
Not recorded
|
ZN ZINC ION × 2
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;7% PEG3350, 150 mM magnesium chloride, 100 mM HEPES sodium, pH 7.0
|
Resolution 5.50 Å
R-free 0.328
|
|
4YLN
E. coli Transcription Initiation Complex - 17-bp spacer and 4-nt RNA
Deposited 2015-03-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Heteromer;Protein × 6
PDB declaration: nonameric
|
Chain K
2–91(90 aa)
|
Not recorded
|
ZN ZINC ION × 2
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;7% PEG3350, 150 mM magnesium chloride, 100 mM HEPES sodium, pH 7.0
|
Resolution 5.50 Å
R-free 0.328
|
|
4YLN
E. coli Transcription Initiation Complex - 17-bp spacer and 4-nt RNA
Deposited 2015-03-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Other combination
Heteromer;Protein × 6
PDB declaration: nonameric
|
Chain Q
2–91(90 aa)
|
Not recorded
|
ZN ZINC ION × 2
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;7% PEG3350, 150 mM magnesium chloride, 100 mM HEPES sodium, pH 7.0
|
Resolution 5.50 Å
R-free 0.328
|
|
4YLO
E. coli Transcription Initiation Complex - 16-bp spacer and 4-nt RNA
Deposited 2015-03-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 6
PDB declaration: nonameric
|
Chain E
2–91(90 aa)
|
Not recorded
|
MG MAGNESIUM ION × 1
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;7% PEG3350, 150 mM magnesium chloride, 100 mM HEPES sodium, pH 7.0
|
Resolution 6.00 Å
R-free 0.314
|
|
4YLO
E. coli Transcription Initiation Complex - 16-bp spacer and 4-nt RNA
Deposited 2015-03-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Heteromer;Protein × 6
PDB declaration: nonameric
|
Chain K
2–91(90 aa)
|
Not recorded
|
MG MAGNESIUM ION × 1
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;7% PEG3350, 150 mM magnesium chloride, 100 mM HEPES sodium, pH 7.0
|
Resolution 6.00 Å
R-free 0.314
|
|
4YLO
E. coli Transcription Initiation Complex - 16-bp spacer and 4-nt RNA
Deposited 2015-03-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Other combination
Heteromer;Protein × 6
PDB declaration: nonameric
|
Chain Q
2–91(90 aa)
|
Not recorded
|
MG MAGNESIUM ION × 1
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;7% PEG3350, 150 mM magnesium chloride, 100 mM HEPES sodium, pH 7.0
|
Resolution 6.00 Å
R-free 0.314
|
|
4YLP
E. coli Transcription Initiation Complex - 16-bp spacer and 5-nt RNA
Deposited 2015-03-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 6
PDB declaration: nonameric
|
Chain E
2–91(90 aa)
|
Not recorded
|
ZN ZINC ION × 2
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;7% PEG3350, 150 mM magnesium chloride, 100 mM HEPES sodium, pH 7.0
|
Resolution 5.50 Å
R-free 0.313
|
|
4YLP
E. coli Transcription Initiation Complex - 16-bp spacer and 5-nt RNA
Deposited 2015-03-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Heteromer;Protein × 6
PDB declaration: nonameric
|
Chain K
2–91(90 aa)
|
Not recorded
|
ZN ZINC ION × 2
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;7% PEG3350, 150 mM magnesium chloride, 100 mM HEPES sodium, pH 7.0
|
Resolution 5.50 Å
R-free 0.313
|
|
4YLP
E. coli Transcription Initiation Complex - 16-bp spacer and 5-nt RNA
Deposited 2015-03-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Other combination
Heteromer;Protein × 6
PDB declaration: nonameric
|
Chain Q
2–91(90 aa)
|
Not recorded
|
ZN ZINC ION × 2
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;7% PEG3350, 150 mM magnesium chloride, 100 mM HEPES sodium, pH 7.0
|
Resolution 5.50 Å
R-free 0.313
|